These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37803335)

  • 1. The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study.
    Bavor C; Brotherton JM; Smith MA; Prang KH; McDermott T; Rankin NM; Zammit CM; Jennett CJ; Sultana F; Machalek DA; Nightingale CE;
    BMC Health Serv Res; 2023 Oct; 23(1):1073. PubMed ID: 37803335
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zammit CM; Creagh NS; McDermott T; Smith MA; Machalek DA; Jennett CJ; Prang KH; Sultana F; Nightingale CE; Rankin NM; Kelaher M; Brotherton JML
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Australia's primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study.
    Brotherton JML; McDermott T; Smith MA; Machalek DA; Shilling H; Prang KH; Jennett C; Nightingale C; Zammit C; Pagotto A; Rankin NM; Kelaher M
    Prev Med Rep; 2023 Jun; 33():102213. PubMed ID: 37223565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the renewal of the National Cervical Screening Program in Australia.
    Smith M; Hammond I; Saville M
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
    Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's experiences of the renewed National Cervical Screening Program in Australia 12 months following implementation: a qualitative study.
    Dodd RH; Mac OA; McCaffery KJ
    BMJ Open; 2020 Jul; 10(7):e039041. PubMed ID: 32665351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses.
    Sultana F; Roeske L; Malloy MJ; McDermott TL; Saville M; Brotherton JML
    PLoS One; 2020; 15(1):e0228042. PubMed ID: 31995585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
    Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
    BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'I'm a bit of a champion for it actually': qualitative insights into practitioner-supported self-collection cervical screening among early adopting Victorian practitioners in Australia.
    Zammit C; Creagh N; Nightingale C; McDermott T; Saville M; Brotherton J; Kelaher M
    Prim Health Care Res Dev; 2023 Apr; 24():e31. PubMed ID: 37185205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer prevention in Australia: Planning for the future.
    Saville AM
    Cancer Cytopathol; 2016 Apr; 124(4):235-40. PubMed ID: 26619381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The experience of under-screened and never-screened participants using clinician-supported self-collection cervical screening within the Australian National Cervical Screening Program.
    Creagh NS; Zammit C; Brotherton JM; Saville M; McDermott T; Nightingale C; Kelaher M
    Womens Health (Lond); 2022; 18():17455065221075905. PubMed ID: 35147064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study.
    Chua BWB; Neo P; Ma VY; Lim LM; Ng JSY; Wee HL
    Front Public Health; 2022; 10():853453. PubMed ID: 35958842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening program in Indonesia: is it time for HPV-DNA tests? Results of a qualitative study exploring the stakeholders' perspectives.
    Ekawati FM; Listiani P; Idaiani S; Thobari JA; Hafidz F
    BMC Womens Health; 2024 Feb; 24(1):125. PubMed ID: 38365690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
    Maver PJ; Poljak M
    Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use.
    Smith MA; Gertig D; Hall M; Simms K; Lew JB; Malloy M; Saville M; Canfell K
    BMC Health Serv Res; 2016 Apr; 16():147. PubMed ID: 27112193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study.
    Megersa BS; Bussmann H; Bärnighausen T; Muche AA; Alemu K; Deckert A
    PLoS One; 2020; 15(12):e0243036. PubMed ID: 33306681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.